Cocrystal Pharma COCP
NASDAQ COCP
$1.17 +0.02 (+1.75%)
As of: Oct 1, 2026 · 12:27 PM EDT

Cocrystal Pharma (COCP) Equity Income (2011)

Updated

Cocrystal Pharma (COCP) posted Equity Income of -$42,677 for FY2011, compared with $55,305 in FY2010.

Analysis

Cocrystal Pharma (COCP) Equity Income (2011) Analysis & Trends

  • Business Quant data shows COCP's Equity Income at $55,305 in FY2010.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Equity Income (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn -
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -2.00 Mn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -10.00 Mn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -
10 Cocrystal Pharma 15.86 Mn -6.05 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2011 -6,595.00
API Access

Cocrystal Pharma Equity Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=equity-income&ticker=COCP&period=max&api_key=YOUR_API_KEY